第 1 到 94 筆結果,共 94 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era | WEI-LI MA ; RUEY-LONG HONG ; PEI-JEN LOU ; MING YAO ; SHANG-JU WU ; CHUNG-WU LIN ; CHUN-WEI WANG ; Chang, Chin-Hao; ANN-LII CHENG ; SUNG-HSIN KUO | Cancer medicine | 0 | 0 | |
2 | 2024 | Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific | Guo, Ye; Nakashima, Torahiko; Cho, Byoung Chul; Lim, Darren W-T; Yang, Muh-Hwa; PEI-JEN LOU ; Corry, June; Lin, Jin Ching; Zhu, Guo Pei; Kim, Kyung Hwan; Zhang, Bin; Li, Zhiming; RUEY-LONG HONG ; Ng, Junice Yi Siu; Tan, Ee Min; Liu, Yan Ping; Stylianou, Con; Spiteri, Carmel; Porceddu, Sandro | Oral oncology | 0 | 0 | |
3 | 2023 | A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | Razak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein, George; Solomon, Benjamin; Lim, Darren Wan-Teck; RUEY-LONG HONG ; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre | Targeted oncology | 0 | ||
4 | 2023 | Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis | Petit, Claire; Lee, Anne; Ma, Jun; Lacas, Benjamin; Ng, Wai Tong; Chan, Anthony T C; RUEY-LONG HONG ; Chen, Ming-Yuan; Chen, Lei; Li, Wen-Fei; Huang, Pei-Yu; Tan, Terence; Ngan, Roger K C; Zhu, Guopei; Mai, Hai-Qiang; Hui, Edwin P; Fountzilas, George; Zhang, Li; Carmel, Alexandra; Kwong, Dora L W; Moon, James; Bourhis, Jean; Auperin, Anne; Pignon, Jean-Pierre; Blanchard, Pierre | The Lancet. Oncology | 8 | 8 | |
5 | 2023 | Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma | Lim, Darren Wan-Teck; HSIANG-FONG KAO ; Suteja, Lisda; Li, Constance H; Quah, Hong Sheng; Tan, Daniel Shao-Weng; Tan, Sze-Huey; Tan, Eng-Huat; Tan, Wan-Ling; Lee, Justina Nadia; Wee, Felicia Yu-Ting; Jain, Amit; Goh, Boon-Cher; Chua, Melvin L K; BIN-CHI LIAO ; Ng, Quan Sing; RUEY-LONG HONG ; Ang, Mei-Kim; Yeong, Joe Poh-Sheng; Iyer, N Gopalakrishna | Nature communications | 6 | 1 | |
6 | 2023 | Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial | Chan, A T C; Lee, V H F; RUEY-LONG HONG ; Ahn, M-J; Chong, W Q; Kim, S-B; Ho, G F; Caguioa, P B; Ngamphaiboon, N; Ho, C; Aziz, M A S A; Ng, Q S; Yen, C-J; Soparattanapaisarn, N; Ngan, R K-C; Kho, S K; Tiambeng, M L A; Yun, T; Sriuranpong, V; Algazi, A P; Cheng, A; Massarelli, E; Swaby, R F; Saraf, S; Yuan, J; Siu, L L | Annals of oncology : official journal of the European Society for Medical Oncology | 22 | 13 | |
7 | 2023 | Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma | YU-JU TSENG ; CHUN-NAN CHEN ; RUEY-LONG HONG ; Kung, Woon-Man; ABEL PO-HAO HUANG | Brain sciences | 1 | 1 | |
8 | 2022 | A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma | WEI-WU CHEN ; CHIA-LANG HSU ; RUEY-LONG HONG ; JEN-CHIEH LEE ; Chang, Koping; CHIH-WEI YU ; Chen, San-Chi; JHE-CYUAN GUO ; Chen, Mei-Lu; Hsu, Meng-Chi; Kung, Ting-Fang; ANN-LII CHENG ; Yen, Chueh-Chuan | Clinical cancer research : an official journal of the American Association for Cancer Research | 6 | 6 | |
9 | 2022 | Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis | HSIANG-FONG KAO ; HUAI-CHENG HUANG ; BIN-CHI LIAO ; RUEY-LONG HONG | BMC cancer | 3 | 2 | |
10 | 2022 | Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis | HSIANG-FONG KAO ; BIN-CHI LIAO ; YEN-LIN HUANG ; HUAI-CHENG HUANG ; Chun-Nan Chen ; TSENG-CHENG CHEN ; Hong, Yuan Jing; Chan, Ching Yi; JEAN-SAN CHIA ; RUEY-LONG HONG | Clinical Cancer Research | 35 | 28 | |
11 | 2022 | Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience | Wang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO | Annals of hematology | 11 | 9 | |
12 | 2022 | Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients | Blanchard P.; Lee A.W.M.; Carmel A.; Wai Tong N.; Ma J.; Chan A.T.C.; Hong R.L.; Chen M.-Y.; Chen L.; Li W.-F.; Huang P.-Y.; Kwong D.L.W.; Poh S.S.X.; Ngan R.; Mai H.-Q.; Ollivier C.; Fountzilas G.; Zhang L.; Bourhis J.; Aupérin A.; Lacas B.; Pignon J.-P.; Benhamou E.; Chakrabandhu S.; TC Chan A.; Chen Q.-Y.; Chen Y.; Chappell R.J.; Choi H.; TT Chua D.; Lee Kiang Chua M.; Higgins J.; Hong M.-H.; RUEY-LONG HONG ; Pun Hui E.; Hsiao C.F.; Kam M.; Angeliki Koliou G.; LW Kwong D.; Lai S.-C.; On Lam K.; LeBlanc M.L.; WM Lee A.; Fun Victor Lee H.; Fei Li W.; Ma B.; Mo F.; Moon J.; Tong Ng W.; O'Sullivan B.; Petit C.; Pierre Pignon J.; Poh S.X.; Rücker G.; Sham J.; Lim Soong Y.; Sun Y.; Tan T.; Tang L.-Q.; Tung Y.; Wee J.; Wu X.; Xu T.; Zhang Y.; Zhu G.; on behalf of the MAC-NPC collaborative Group | Clinical and Translational Radiation Oncology | 17 | 18 | |
13 | 2022 | Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048 | Rischin D.; Harrington K.J.; Greil R.; Soulières D.; Tahara M.; de Castro Jr G.; Psyrri A.; Braña I.; Neupane P.; Bratland Å.; Fuereder T.; Hughes B.G.M.; Mesía R.; Ngamphaiboon N.; Rordorf T.; Ishak W.Z.W.; RUEY-LONG HONG ; Mendoza R.G.; Jia L.; Chirovsky D.; Norquist J.; Jin F.; Burtness B. | Oral Oncology | 16 | 10 | |
14 | 2021 | A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus | SHAN-CHI YU ; KUAN-YIN KO ; SHU-CHUN TENG ; TAI-CHUNG HUANG ; Lo, Hsiao Ting; Chieh-Lung Cheng ; MING YAO ; RUEY-LONG HONG ; Chun-Nan Chen ; TSENG-CHENG CHEN ; TSUNG-LIN YANG | Infectious Diseases and Therapy | 1 | 2 | |
15 | 2020 | Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141) | Yen C.-J.; Kiyota N.; Hanai N.; Takahashi S.; Yokota T.; Iwae S.; Shimizu Y.; RUEY-LONG HONG ; Goto M.; Kang J.-H.; Li W.S.K.; Ferris R.L.; Gillison M.; Endo T.; Jayaprakash V.; Tahara M. | Head and Neck | 27 | 19 | |
16 | 2020 | The impacts of intra-arterial chemotherapy on head and neck microvascular reconstruction | CHEN-HSIANG KUAN ; Chung M.-J.; RUEY-LONG HONG ; Tseng T.-Y.; HAO-CHIH TAI ; NAI-CHEN CHENG ; JUNG-HSIEN HSIEH ; SHYUE-YIH HORNG ; HONG-SHIEE LAI | Journal of the Formosan Medical Association | 2 | 1 | |
17 | 2019 | Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study | Burtness B.; Harrington K.J.; Greil R.; Souli?res D.; Tahara M.; de Castro G.; Jr, Psyrri A.; Bast? N.; Neupane P.; Bratland ?.; Fuereder T.; Hughes B.G.M.; Mes?a R.; Ngamphaiboon N.; Rordorf T.; Wan Ishak W.Z.; RUEY-LONG HONG ; Gonz?lez Mendoza R.; Roy A.; Zhang Y.; Gumuscu B.; Cheng J.D.; Jin F.; Rischin D.; Lerzo G.; Tatangelo M.; Varela M.; Zarba J.J.; Boyer M.; Gan H.; Gao B.; Hughes B.; Mallesara G.; Taylor A.; Burian M.; Barrios C.H.; de Castro Junior D.O.; Castro G.; Franke F.A.; Girotto G.; Lima I.P.F.; Nicolau U.R.; Pinto G.D.J.; Santos L.; Victorino A.-P.; Chua N.; Couture F.; Gregg R.; Hansen A.; Hilton J.; McCarthy J.; Soulieres D.; Ascui R.; Gonzalez P.; Villanueva L.; Torregroza M.; Zambrano A.; Holeckova P.; Kral Z.; Melichar B.; Prausova J.; Vosmik M.; Andersen M.; Gyldenkerne N.; Jurgens H.; Putnik K.; Reinikainen P.; Gruenwald V.; Laban S.; Aravantinos G.; Boukovinas I.; Georgoulias V.; Kwong D.; Al-Farhat Y.; Csoszi T.; Erfan J.; Horvai G.; Landherr L.; Remenar E.; Ruzsa A.; Szota J.; Billan S.; Gluck I.; Gutfeld O.; Popovtzer A.; Benasso M.; Bui S.; Ferrari V.; Licitra L.; Nole F.; Fujii T.; Fujimoto Y.; Hanai N.; Hara H.; Matsumoto K.; Mitsugi K.; Monden N.; Nakayama M.; Okami K.; Oridate N.; Shiga K.; Shimizu Y.; Sugasawa M.; Takahashi M.; Takahashi S.; Tanaka K.; Ueda T.; Yamaguchi H.; Yamazaki T.; Yasumatsu R.; Yokota T.; Yoshizaki T.; Kudaba I.; Stara Z.; Cheah S.K.; Aguilar Ponce J.; Gonzalez Mendoza R.; Hernandez Hernandez C.; Medina Soto F.; Buter J.; Hoeben A.; Oosting S.; Suijkerbuijk K.; Bratland A.; Brydoey M.; Alvarez R.; Mas L.; Caguioa P.; Querol J.; Regala E.E.; Tamayo M.B.; Villegas E.M.; Kawecki A.; Karpenko A.; Klochikhin A.; Smolin A.; Zarubenkov O.; Goh B.C.; Cohen G.; du Toit J.; Jordaan C.; Landers G.; Ruff P.; Szpak W.; Tabane N.; Brana I.; Iglesias Docampo L.; Lavernia J.; Mesia R.; Abel E.; Muratidu V.; Nielsen N.; Cristina V.; Rothschild S.; Wang H.-M.; Yang M.-H.; Yeh S.-P.; Yen C.-J.; Soparattanapaisarn N.; Sriuranpong V.; Aksoy S.; Cicin I.; Ekenel M.; Harputluoglu H.; Ozyilkan O.; Harrington K.; Agarwala S.; Ali H.; Alter R.; Anderson D.; Bruce J.; Campbell N.; Conde M.; Deeken J.; Edenfield W.; Feldman L.; Gaughan E.; Goueli B.; Halmos B.; Hegde U.; Hunis B.; Jotte R.; Karnad A.; Khan S.; Laudi N.; Laux D.; Martincic D.; McCune S.; McGaughey D.; Misiukiewicz K.; Mulford D.; Nadler E.; Nunnink J.; Ohr J.; O'Malley M.; Patson B.; Paul D.; Popa E.; Powell S.; Redman R.; Rella V.; Rocha Lima C.; Sivapiragasam A.; Su Y.; Sukari A.; Wong S.; Yilmaz E.; Yorio J. | The Lancet | 1773 | 1531 | |
18 | 2019 | Primary intradural extramedullary spinal mesenchymal chondrosarcoma: Case report and literature review | CHIH-WEI CHEN ; Chen I.-H.; MING-HSIAO HU ; JEN-CHIEH LEE ; Huang H.-Y.; RUEY-LONG HONG ; SHU-HUA YANG | BMC Musculoskeletal Disorders | 8 | 7 | |
19 | 2019 | Co-encapsulation of chlorin e6 and chemotherapeutic drugs in a pegylated liposome enhance the efficacy of tumor treatment: Pharmacokinetics and therapeutic efficacy | Po-Chun Peng; RUEY-LONG HONG ; Tsuimin Tsai; CHIN-TIN CHEN | Pharmaceutics | 12 | 10 | |
20 | 2019 | Prognostic factors and treatment outcomes of adult patients with rhabdomyosarcoma after multimodality treatment | Liu Y.-T.; CHUN-WEI WANG ; RUEY-LONG HONG ; SUNG-HSIN KUO | Anticancer Research | 14 | 11 | |
21 | 2018 | Pembrolizumab for the treatment of advanced salivary gland carcinoma | Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG ; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B. | American Journal of Clinical Oncology: Cancer Clinical Trials | 151 | 119 | |
22 | 2018 | Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study | RUEY-LONG HONG ; Hsiao C.F.; Ting L.L.; JENG-YUH KO ; CHUN-WEI WANG ; Chang J.T.C.; PEI-JEN LOU ; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. | Annals of Oncology | 99 | 92 | |
23 | 2018 | A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing | Lizotte P.H.; RUEY-LONG HONG ; Luster T.A.; Cavanaugh M.E.; Taus L.J.; Wang S.; Dhaneshwar A.; Mayman N.; Yang A.; Kulkarni M.; Badalucco L.; Fitzpatrick E.; HSIANG-FONG KAO ; Kuraguchi M.; Bittinger M.; Kirschmeier P.T.; Gray N.S.; Barbie D.A.; Janne P.A. | Cancer Immunology Research | 60 | 53 | |
24 | 2017 | A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141 | Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG ; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M. | Oral Oncology | 81 | 69 | |
25 | 2017 | Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma | WEN-CHI YANG ; CHUN-WEI WANG ; RUEY-LONG HONG ; CHIAO-LING TSAI ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; ANN-LII CHENG ; SUNG-HSIN KUO | Journal of Radiation Research | 9 | 9 | |
26 | 2017 | Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma | JENNY LING-YU CHEN ; YU-SEN HUANG ; SUNG-HSIN KUO ; RUEY-LONG HONG ; JENG-YUH KO ; PEI-JEN LOU ; CHUN-WEI WANG | Oncotarget | 17 | 15 | |
27 | 2017 | Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate-cysteine ligase catalytic subunit in head and neck squamous cell carcinoma | Liu C.-W.; KUO-TAI HUA ; Li K.-C.; HSIANG-FONG KAO ; RUEY-LONG HONG ; JENG-YUH KO ; Hsiao M.; Kuo M.-L.; CHING-TING TAN | Molecular Cancer Therapeutics | 44 | 40 | |
28 | 2017 | Terminally Ill Taiwanese Cancer Patients’ and Family Caregivers’ Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional Studies | Liu T.-W.; Wen F.-H.; Wang C.-H.; RUEY-LONG HONG ; Chow J.-M.; Chen J.-S.; Chiu C.-F.; Tang S.T. | Journal of Pain and Symptom Management | 17 | 16 | |
29 | 2015 | Nasopharyngeal Carcinoma and Pulmonary Lymphoepithelioma-like Carcinoma-Metastases or Synchronous Second Primary Cancer | MING-KAI CHUANG ; RUEY-LONG HONG | Journal of Cancer Research and Practice | 0 | 0 | |
30 | 2015 | Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment | Peng P.-C.; RUEY-LONG HONG ; Tsai Y.-J.; Li P.-T.; Tsai T.; Chen C.-T. | Lasers in Surgery and Medicine | 32 | 32 | |
31 | 2015 | α-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer | Wu C.-H.; Kuo Y.-H.; RUEY-LONG HONG ; Wu H.-C. | Science Translational Medicine | 49 | 27 | |
32 | 2013 | Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence | JENNY LING-YU CHEN ; YU-SEN HUANG ; SUNG-HSIN KUO ; YA-FANG CHEN ; RUEY-LONG HONG ; JENG-YUH KO ; PEI-JEN LOU ; CHIAO-LING TSAI ; WAN-YU CHEN ; CHUN-WEI WANG | Strahlentherapie und Onkologie | 27 | 24 | |
33 | 2013 | An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma | Le Q.-T.; Zhang Q.; Cao H.; Cheng A.-J.; Pinsky B.A.; RUEY-LONG HONG ; Chang J.T.; CHUN-WEI WANG ; Tsao K.-C.; Lo Y.M.D.; Lee N.; Ang K.K.; Chan A.T.C.; Chan K.C.A. | Clinical Cancer Research | 136 | 119 | |
34 | 2013 | Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial | Urba S.; RUEY-LONG HONG ; Hossain A.M.; Cheng R.; Orlando M. | Asia-Pacific Journal of Clinical Oncology | 1 | 1 | |
35 | 2013 | Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication | Hu Z.; Wang J.; Yao T.; RUEY-LONG HONG ; Zhang K.; Gao H.; Wu X.; Li J.; Bai C.; Yen Y. | Lung Cancer | 6 | 6 | |
36 | 2012 | Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study | Urba S.; Van Herpen C.M.L.; Sahoo T.P.; Shin D.M.; Licitra L.; Mezei K.; Reuter C.; Hitt R.; Russo F.; Chang S.-C.; Hossain A.M.; Frimodt-Moller B.; Koustenis A.; RUEY-LONG HONG | Cancer | 38 | 30 | |
37 | 2012 | Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging | Wu L.-A.; HON-MAN LIU ; CHUN-WEI WANG ; YA-FANG CHEN ; RUEY-LONG HONG ; JENG-YUH KO | Radiology | 22 | 20 | |
38 | 2012 | Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas | Lin Y.-C.; Chen K.-C.; CHING-HUNG LIN ; KUAN-TING KUO ; JENG-YUH KO ; RUEY-LONG HONG | International Journal of Oral and Maxillofacial Surgery | 22 | 19 | |
39 | 2012 | Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer | Chua D.T.T.; Yiu H.H.-Y.; Seetalarom K.; Ng A.W.-Y.; Kurnianda J.; Shotelersuk K.; Krishnan G.; RUEY-LONG HONG ; Yang M.-H.; Wang C.-H.; Sze W.-K.; Ng W.-T. | Head and Neck | 33 | 32 | |
40 | 2012 | A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor | SHIH-HUNG YANG ; CHIA-CHI LIN ; ZHONG-ZHE LIN ; Tseng Y.-L.; RUEY-LONG HONG | Investigational New Drugs | 34 | 28 | |
41 | 2012 | Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy | ZHONG-ZHE LIN ; CHIUN HSU ; Hu F.-C.; YU-YUN SHAO ; DWANG-YING CHANG ; CHIH-HSIN YANG ; RUEY-LONG HONG ; CHIH-HUNG HSU ; ANN-LII CHENG | Oncologist | 8 | 10 | |
42 | 2012 | Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation | WAN-YU CHEN ; SUNG-HSIN KUO ; YU-HSUAN CHEN ; Lu S.-H.; CHIAO-LING TSAI ; CHIA-HSIEN CHENG ; RUEY-LONG HONG ; YA-FANG CHEN ; Hsu C.-J.; Lin K.-N.; JENG-YUH KO ; PEI-JEN LOU ; CHENG-PING WANG ; Chong F.-C.; CHUN-WEI WANG | International Journal of Radiation Oncology Biology Physics | 13 | 12 | |
43 | 2010 | Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma | YU-YUN SHAO ; RUEY-LONG HONG | Oral Oncology | 6 | 7 | |
44 | 2010 | The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients | RUOH-FANG YEN ; Chen C.-Y.; MEI-FANG CHENG ; YEN-WEN WU ; Shiau Y.-C.; Wu K.; RUEY-LONG HONG ; CHONG-JEN YU ; Wang K.-L.; RONG-SEN YANG | Nuclear Medicine Communications | 51 | 40 | |
45 | 2009 | The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma | RUOH-FANG YEN ; Yen M.-F.; RUEY-LONG HONG ; KAI-YUAN TZEN ; Chien C.-R.; Chen, Tony Hsiu Hsi | Academic Radiology | 23 | 21 | |
46 | 2009 | Nasion swelling as the presenting symptom of lung adenocarcinoma | CHUN-TA HUANG ; RUEY-LONG HONG | Journal of Thoracic Oncology | 9 | 9 | |
47 | 2009 | Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma | RUOH-FANG YEN ; Ting L.-L.; MEI-FANG CHENG ; YEN-WEN WU ; KAI-YUAN TZEN ; RUEY-LONG HONG | Head and Neck | 6 | 8 | |
48 | 2008 | A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline | RUEY-LONG HONG ; CHING-HUNG LIN ; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. | Cancer Chemotherapy and Pharmacology | 9 | 7 | |
49 | 2008 | Fatal thrombocytopenia after oxaliplatin-based chemotherapy | YU-YUN SHAO ; RUEY-LONG HONG | Anticancer Research | 19 | 20 | |
50 | 2006 | Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma | Wang C.-C.; Chang J.-Y.; Liu T.-W.; Lin C.-Y.; Yu Y.-C.; RUEY-LONG HONG | Head and Neck | 51 | 46 | |
51 | 2006 | Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis | CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; RUEY-LONG HONG ; Chang C.-J.; ANN-LII CHENG | Cancer Epidemiology Biomarkers and Prevention | 67 | 51 | |
52 | 2005 | Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma | RUOH-FANG YEN ; Chen, Tony Hsiu Hsi ; Ting L.-L.; KAI-YUAN TZEN ; Pan M.-H.; RUEY-LONG HONG | European Journal of Nuclear Medicine and Molecular Imaging | 46 | 38 | |
53 | 2005 | Response of refractory osteosarcoma to thalidomide and celecoxib | YU-CHIEH TSAI ; CHEN-TU WU ; RUEY-LONG HONG | Lancet Oncology | 15 | 14 | |
54 | 2005 | Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate | CHING-HUNG LIN ; RUOH-FANG YEN ; YUNG-MING JENG ; Tzen C.-Y.; CHIUN HSU ; RUEY-LONG HONG | Head and Neck | 40 | 30 | |
55 | 2005 | Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma | RUOH-FANG YEN ; RUEY-LONG HONG ; KAI-YUAN TZEN ; Pan M.-H.; HSIU-HSI CHEN | Journal of Nuclear Medicine | 52 | 41 | |
56 | 2005 | Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma | Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG ; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. | Journal of Clinical Oncology | 262 | 217 | |
57 | 2004 | Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma | Li C.-C.; HWEI-FANG TIEN ; JIH-LUH TANG ; MING YAO ; YAO-CHANG CHEN ; Su I.-J.; Hsu S.-M.; RUEY-LONG HONG | Cancer | 168 | 142 | |
58 | 2004 | Effect of 5-Aminolevulinic Acid-Mediated Photodynamic Therapy on MCF-7 and MCF-7/ADR Cells | Tsai, Tsuimin; RUEY-LONG HONG ; JUI-CHANG TSAI ; PEI-JEN LOU ; Ling, I-Fang; Chen, Chin-Tin | Lasers in Surgery and Medicine | 75 | 62 | |
59 | 2004 | Recent advances in the treatment of nasopharyngeal carcinoma | Chang J.T.-C.; JENQ-YUH KO ; RUEY-LONG HONG | Journal of the Formosan Medical Association | |||
60 | 2004 | Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA | RUEY-LONG HONG ; Lin C.-Y.; Ting L.-L.; JENG-YUH KO ; Hsu M.-M. | Cancer | 46 | 36 | |
61 | 2003 | Clinicopathologic characteristics and prognoses of gastric cancer in patients with a positive familial history of cancer | Lee, Wei-Jei; RUEY-LONG HONG ; I-RUE LAI ; CHIUNG-NIEN CHEN ; PO-HUANG LEE ; Huang, Ming-Tegh | Journal of clinical gastroenterology | 23 | 19 | |
62 | 2003 | Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35 | WEI-CHU CHIE ; RUEY-LONG HONG ; Lai C.-C.; Ting L.-L.; Hsu M.-M. | Quality of Life Research | 89 | 76 | |
63 | 2003 | A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma | RUEY-LONG HONG ; Tseng Y.-L. | Cancer Chemotherapy and Pharmacology | 41 | 38 | |
64 | 2003 | Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma | SHANG-YI HUANG ; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO ; RUEY-LONG HONG ; Tsai W.; Wang C.-H.; HWEI-FANG TIEN ; MING-CHING SHEN ; YAO-CHANG CHEN | Annals of Hematology | 12 | 10 | |
65 | 2002 | Prognostic value of multidrug resistance 1, glutathione-S-transferase-π and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy | CHIH-HUNG HSU ; Chen C.-L.; RUEY-LONG HONG ; Chen K.-L.; Lin J.-F.; ANN-LII CHENG | Oncology | 31 | 25 | |
66 | 2002 | Reappraisal of the new UICC staging system for gastric cancer: Problem in lymph node stage | Lee W.-J.; RUEY-LONG HONG ; I-RUE LAI ; Chen C.-N.; PO-HUANG LEE ; Chung K.-C. | Hepato-Gastroenterology | 14 | 12 | |
67 | 2002 | Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis | MING-SHIANG WU ; Lee C.-W.; JIN-CHUAN SHEU ; CHIA-TUNG SHUN ; HSIU-PO WANG ; RUEY-LONG HONG ; Lee W.-J.; Lin J.-T. | Hepato-Gastroenterology | 22 | 21 | |
68 | 2002 | Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: A kinetic and efficacy study | Tseng Y.-L.; Liu J.-J.; RUEY-LONG HONG | Molecular Pharmacology | 218 | 205 | |
69 | 2002 | Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: Stability, pharmacokinetic and therapeutic evaluation | Liu J.-J.; RUEY-LONG HONG ; WEN-FANG CHENG ; Hong K.; FU-HSIUNG CHANG ; Tseng Y.-L. | Anti-Cancer Drugs | 38 | 35 | |
70 | 2001 | Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma | RUEY-LONG HONG ; Ting L.-L.; JENG-YUH KO ; Hsu M.-M.; Sheen T.-S.; PEI-JEN LOU ; CHIA-CHUN WANG ; Chung N.-N.; Lui L.T. | Journal of Clinical Oncology | 96 | 86 | |
71 | 2001 | Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma | Lee Y.-L.; Ye Y.-L.; Yu C.-I.; Wu Y.-L.; Lai Y.-L.; Ku P.-H.; RUEY-LONG HONG ; BOR-LUEN CHIANG | Human Gene Therapy | 42 | 38 | |
72 | 2001 | Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases | Hsu M.-M; RUEY-LONG HONG ; Ting L.-L; JENG-YUH KO ; Sheen T.-S; PEI-JEN LOU | Archives of Otolaryngology - Head and Neck Surgery | 50 | 43 | |
73 | 2001 | Anaphylaxis after propocol infusion for Port-A-Cath insertion in a 35-year old man | Tsai M.-H.; PING-HUNG KUO ; RUEY-LONG HONG ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 13 | 12 | |
74 | 2001 | Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: The relation between pharmacokinetic property and toxicity | RUEY-LONG HONG ; Tseng Y.-L. | Cancer | 81 | ||
75 | 2000 | DNA content of nasopharyngeal carcinoma: An independent prognostic indicator | Hsu M.-M; Chiou C.-R; JENG-YUH KO ; Sheen T.-S; RUEY-LONG HONG ; Ting L.-L. | Cancer Detection and Prevention | |||
76 | 2000 | Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study | RUEY-LONG HONG ; Tseng Y.-L.; FU-HSIUNG CHANG | Annals of Oncology | 22 | 19 | |
77 | 1999 | Curcumin inhibits tyrosine kinase activity of p185(neu) and also depletes p185(neu1) | RUEY-LONG HONG ; Spohn W.H.; Hung M.-C. | Clinical Cancer Research | 154 | 136 | |
78 | 1999 | Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial? | RUEY-LONG HONG ; Huang C.-J.; Tseng Y.-L.; VICTOR FEI PANG ; Chen S.-T.; Liu J.-J.; FU-HSIUNG CHANG | Clinical Cancer Research | |||
79 | 1999 | Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model | Tseng Y.-L.; RUEY-LONG HONG ; Tao M.-H.; FU-HSIUNG CHANG | International Journal of Cancer | 62 | ||
80 | 1999 | Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study | RUEY-LONG HONG ; Sheen T.S.; JENG-YUH KO ; Hsu M.M.; CHIA-CHUN WANG ; Ting L.L. | British Journal of Cancer | 32 | 32 | |
81 | 1998 | Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties | Zhang L.; Lau Y.-K.; Xi L.; RUEY-LONG HONG ; Kim D.S.H.L.; Chen C.-F.; Hortobagyi G.N.; Chang C.-J.; Hung M.-C. | Oncogene | 115 | 103 | |
82 | 1998 | Overexpression of p53 predicts shorter survival in diffuse type gastric cancer | WEN-JENG LEE ; CHIA-TUNG SHUN ; RUEY-LONG HONG ; MING-SHIANG WU ; KING-JEN CHANG ; Chen K.-M. | British Journal of Surgery | 19 | 19 | |
83 | 1998 | Relation between Histological Intensity of Transforming Growth Factor-β Isoforms in Human Osteosarcoma and the Rate of Lung Metastasis | RONG-SEN YANG ; CHEN-TU WU ; Lin K.-H.; RUEY-LONG HONG ; Liu T.-K.; KAI-HSIN LIN | Tohoku Journal of Experimental Medicine | 23 | 21 | |
84 | 1997 | MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer | CHIUN HSU ; KUN-HUEI YEH ; RUEY-LONG HONG ; CHIH-HSIN YANG ; Lin M.-T.; YAO-CHANG CHEN ; ANN-LII CHENG | Journal of the Formosan Medical Association | 4 | 3 | |
85 | 1997 | A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers | KUN-HUEI YEH ; ANN-LII CHENG ; Lin M.-T.; RUEY-LONG HONG ; CHIH-HUNG HSU ; Lin J.-F.; KING-JEN CHANG ; PO-HUANG LEE ; YAO-CHANG CHEN | Anticancer Research | 32 | 27 | |
86 | 1996 | Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: A retrospective analysis covering a 34-year period | Chen H.H.W.; Fong L.; Su I.-J.; Ting L.-L.; RUEY-LONG HONG ; Leung H.W.C.; Lui L.T. | Radiotherapy and Oncology | 36 | 32 | |
87 | 1995 | Expressions of E-Cadherin and Exon V6-Containing Isoforms of CD44 and their Prognostic Values in Human Transitional Cell Carcinoma | RUEY-LONG HONG ; YEONG-SHIAU PU ; Hsieh T.-S.; Chu J.-S.; Lee W.-J. | The Journal of Urology | 55 | 55 | |
88 | 1995 | Clinicopathologic characteristics of helicobacter pyloric seropositive gastric adenocarcinomas | Lee W.-J.; Lin J.-T.; WEN-CHUNG LEE ; CHIA-TUNG SHUN ; RUEY-LONG HONG ; ANN-LII CHENG ; PO-HUANG LEE ; Wei T.-C.; Chen K.-M. | Journal of Clinical Gastroenterology | 13 | 13 | |
89 | 1995 | Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas | RUEY-LONG HONG ; WEN-JENG LEE ; CHIA-TUNG SHUN ; Chu J.-S.; YAO-CHANG CHEN | Oncology | 52 | 47 | |
90 | 1995 | Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma | RUEY-LONG HONG ; YEONG-SHIAU PU ; Chu J.-S.; Lee W.-J.; YAO-CHANG CHEN ; Wu C.-W. | Cancer Letters | 33 | 33 | |
91 | 1994 | Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study | ANN-LII CHENG ; Su I.-J.; Chen C.-C.; HWEI-FANG TIEN ; Lay J.-D.; Chen B.-R.; YEONG-SHIAU PU ; RUEY-LONG HONG ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN | Journal of Clinical Oncology | 50 | 46 | |
92 | 1993 | Lymphoblast colony-culture assay in acute lymphoblastic leukemia: A quantitative approach | RUEY-LONG HONG ; Shen S.-W.; Lin M.-T.; HWEI-FANG TIEN ; CHIH-HSIN YANG ; YAO-CHANG CHEN | Leukemia Research | 3 | 1 | |
93 | 1992 | Late survival of non-small cell lung cancer patients with brain metastases: Influence of treatment | Chang D.-B.; PAN-CHYR YANG ; KWEN-TAY LUH ; Kuo S.-H.; RUEY-LONG HONG ; LI-NA LEE | Chest | 61 | 44 | |
94 | 1992 | Hodgkin's disease and non-hodgkin's lymphoma containing reed-sternberg-like giant cells in Taiwan: A clinicopathologic analysis of 50 cases | RUEY-LONG HONG ; Su I.-J.; YAO-CHANG CHEN ; Hsieh H.-C.; Wang C.-H.; Liu C.-H.; MING-CHING SHEN | Cancer | 7 | 8 |